SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: ayahuasca who wrote (29664)3/26/1999 9:26:00 AM
From: kendall harmon  Read Replies (1) | Respond to of 120523
 
CLB buy rating!!!

Princeton, New Jersey, March 26 (Bloomberg Data) -- Core Laboratories N.V. (CLB US) was reinstated ''buy'' by analyst Gordon T. Hall at Credit Suisse First Boston Inc. The 12-month target price is $25.00 per share.



To: ayahuasca who wrote (29664)3/26/1999 9:40:00 AM
From: SMALL FRY  Respond to of 120523
 
It appears the good little people are winning right now... plan your exit correctly... some bad medium people (Asensio) will be scampering to cover in a short while if this keeps on...

SF